Retinopathy of prematurity in muutiple births: risk analysis for plus disease;Enfermedad plus en la retinopatía del prematuro de gestación múltiple. análisis de riesgo

Archivos de la Sociedad Espanola de Oftalmologia

Volumn 84, Issue 4, 2009, Pages 191-198

  Garcia Serrano J L ^a,d   Ramirez Garcia M C ^b,d   Pinar Molina, R ^c,d  

^a Facultativo Especialista de Área de Oftalmología ^*  (Spain)

^b Unidad de Cuidados Intensivos Pediatría y Neonatal

^c Programa ROP

^d HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

Author keywords

Adverse effects; Apgar score; Multiple birth; Plus disease; Retinopathy of prematurity; Risk factors; Weight gain

Indexed keywords

APGAR SCORE; ARTICLE; ARTIFICIAL VENTILATION; DISEASE COURSE; FEMALE; GESTATIONAL AGE; HUMAN; LOW BIRTH WEIGHT; MALE; MULTIPLE PREGNANCY; NEWBORN; PATENT DUCTUS ARTERIOSUS; PATHOLOGY; PREDICTION AND FORECASTING; PREMATURITY; RETINA BLOOD VESSEL; RETROLENTAL FIBROPLASIA; RISK ASSESSMENT; STATISTICAL MODEL; TWINS; WEIGHT GAIN;

APGAR SCORE; DISEASE PROGRESSION; DISEASES IN TWINS; DUCTUS ARTERIOSUS, PATENT; FEMALE; GESTATIONAL AGE; HUMANS; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; INFANT, PREMATURE; LOGISTIC MODELS; MALE; PREDICTIVE VALUE OF TESTS; RESPIRATION, ARTIFICIAL; RETINAL VESSELS; RETINOPATHY OF PREMATURITY; RISK ASSESSMENT; TRIPLETS; WEIGHT GAIN;

EID: 68949212907     PISSN: 03656691     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. 1. Hardy RJ, Palmer EA, Dobson V, Summers CG, Phelps DL, Quinn GE, et al. Risk analysis of prethreshold retinopathy of prematurity. Arch Ophthalmol 2003; 121: 16971701. (Pubitemid 37517434)
2. Early Treatment For Retinopathy Of Prematurity Cooperative Group. Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial. Arch Ophthalmol 2003; 121:1684-1694.
3. Good WV, Early Treatment for Retinopathy of Prematurity Cooperative Group. Final results of the early treatment for retinopathy of prematurity (ETROP) randomized trial. Trans Am Ophthalmol Soc 2004; 102: 233-250.
4. Multicenter trial of Cryotherapy for retinopathy of prematurity. Preliminary results. Cryotheraphy for retinopathy of prematurity Cooperative Group. Arch Ophthalmol 1988; 106: 471-479.
5. Supplemental Therapeutic Oxygen for Prethreshold Retinopathy Of Prematurity (STOP-ROP), a randomized, controlled trial. I: primary outcomes. Pediatrics 2000; 105: 295-310.
6. International Committee for the Classification of Retinopathy of Prematurity. The International Classification of Retinopathy of Prematurity revisited. Arch Ophthalmol 2005; 123: 991-999.
7. Gelman R, Martinez-Perez ME, Vanderveen DK, Mosko witz A, Fulton AB. Diagnosis of plus disease in retinopathy of prematurity using retinal image multiScale Analysis. Invest Ophthalmol Vis Sci 2005; 46: 4734-4738.
8. Wallace DK, Freedman SF, Zao Z, Jung SH. Accuracy of ROP tool vs individual examiners in assessing retinal vascular tortuosity. Arch Ophthalmol 2007; 125: 15231530.
9. Funnell CL Dabbs TR. Assisted conception and retinopathy of prematurity: 8 year follow-up study. Eye 2007; 21: 383-386.
10. Potter JW. El dibujo del fondo. In: Potter JW, Semes LP, Cavalferano AA, Garston MJ. Oftalmoscopia binocular indirecta. Barcelona: JIMS, 1991; 69-79.
11. Rodríguez-Hurtado FJ, Cañizares JM. Despistaje de la retinopatía del prematuro. Nuestra experiencia sobre los límites de peso al nacer, edad gestacional y otros factores de riesgo. Arch Soc Esp Oftalmol 2006; 81: 275-279.
12. Middleton WD, Kurtz AB, Hertzberg BS. Gestación múltiple. In: Middleton WD, Kurtz AB, Hertzberg BS. Ecografía. Madrid: Marban. 2005; 515-529.
13. 13. Strauss A, Paek BW, Genzel-Boroviczény O, Schulze A, Janssen U, Hepp H. Multifetal gestation-maternal and perinatal outcome of 112 pregnancies. Fetal Diagn Ther 2002; 17: 209-217. (Pubitemid 34638982)
14. 14. Luke B, Brown MB, Hediger ML Misiunas RB, Anderson E. Perinatal and early childhood outcomes of twins versus triplets. Twin Res Hum Genet 2006; 9: 81-88. (Pubitemid 43384797)
15. Landmann E, Misselwitz B, Steiss JO, Gartner L. Mortality an morbidity of neonates born at < 26 weeks of gestation (1998-2003). A population-based study. J Perinat Med 2008; 36:168-174.
16. 16. Friling R, Axer-Siegel R, Hersocavici Z, Weinberger D, Sirota L, Snir M. Retinopathy of prematurity in assisted versus natural conception and singleton versus multiple births. Ophthalmology 2007; 114: 321-324. (Pubitemid 46161821)
17. Darlow BA, Hutchinson JL, Henderson-Smart DJ, Donoghue DA, Simpson JM, Evans NJ, et al. Prenatal risk factors for severe retinopathy of prematurity among very preterm infants of the Australian an New Zealand Neonatal Network. Pediatrics 2005; 115: 990-996.
18. Montañez FJ, Olea JL. Once años de experiencia en el manejo de la retinopatía del prematuro en las islas Bafeares. Arch Soc Esp Oftalmol 2005; 80:713-718.
19. 19. JaIaIi S, Madhavi C, Reddy GP, Nutheti R. Pilot study on in vivo evaluation of retinal vascular maturity in newborn infants in the context of retinopathy of prematurity. Am J Ophthalmol 2006; 142: 181-183. (Pubitemid 43946781)
20. Chye JK, Lim CT, Leonq HL, Wonq PK. Retinopathy of prematurity in very low birth weight infants. Ann Acad Med Singapore 1999; 28:193-198.
21. Flynn JT. Acute proliferative retrolental fibroplasia: multivariate risk analysis. Trans Am Ophthalmol Soc 1983; 81: 549-591.
22. Müller II, Weiss C, Kuntz S, Akkoyun I, Schaible T. Are there predictors for proliferative retinopathy of prematurity and is supplemental oxygen a useful conservative treatment option? Klin Padiatr2005; 217: 53-60.
23. 23. Shah VA, Yea CL Ling YL, Ho LY. Incidence, risk factors of retinopathy of prematurity among very low birth weight infants in Singapore. Ann Acad Med Singapore 2005; 34: 169-178. (Pubitemid 40545454)
24. Hernandez M, Orduña C, Bosch V, Salinas R; Alcaraz JL, Marín JM. Retinopatía del prematuro en la región de Murcia (España). Incidencia y gravedad. Arch Soc Esp Oftalmol 2008; 83: 423-428.
25. Peralta-Calvo J, Abelairas-Gómez J, Femández-GuardioIa JM, Sánchez-Jacob E. Retinopatía del prematuro (RP) I. Definición y clasificación. Teorías etiológicas, profilaxis y tratamientos médicos. In: Fonseca-Domingo A. Actualización en cirugía Oftálmica pediátrica. Madrid: MacLine SL. 2000; 157-166.
26. Padilla-Vinuesa MC. Alto riesgo obstétrico. In: RuizExtremera A. Niños de riesgo. Programas de atención temprana. Madrid: Norma-Capitel. 2003: 65-74.
27. Fortes Filho JB, Dill JC, Ishizaki A, Aguiar WW, Silveira RC, Procianoy RS. Score for neonatal acute physiology and perinatal extension II as a predictor of retinopathy of prematurity: Study in 304 very-low-birth-weight preterm infants. Ophthalmologica 2009; 223:177-182.
28. Hagadorn JI, Richardson DK, Schmid CH, Cole CH. Cumulative illness severity and progression from moderate to severe retinopathy of prematurity. J Perinatal 2007; 27: 502-509.
29. Drevenstedt GL, Crimmins EM, Vasunilashom S, Finch CE. The rise and fall of excess male infant mortality. Proc Natl Acad Sci USA 2008; 105: 5016-5021.
30. 30. IIuo DM, Dong FT, Dai RP, Chu J, Yu WII. Prevalence and risk factors of retinopathy of prematurity. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2006; 28: 567-569. (Pubitemid 44560175)
31. Bonotto LB, Moreira AT, Carvalho DS. Prevalence of retinopathy of prematurity in premature babies examined during the period 1992-1999, Joinville (SC): evaluation of associated risks-screening). Arq Bras Oftalmol 2007; 70:55-61.
32. 32. Ryan S. Nutrition in neonatal chronic lung disease. Eur J Pediatr 1998; 157 Sl: 19-22. (Pubitemid 128689742)
33. Larroque B, Ancel PY, Marret S, Marchand L André M, Arnaud C, et al. Neurodevelopmental disabilities and special care of 5-year-old children born before. 33 weeks of gestation (the EPIPAGE study): a longitudinal cohort study. Lancet 2008; 371: 813-820.
34. 34. Spear ML, Hassink SG, Leef K, O'Connor DM, Kirwin SM, Locke R, et al. Immaturity or starvation? longitudinal study ofleptin levels in premature infants. Biol Neonate 2001; 80: 35-40. (Pubitemid 32727525)
35. Lo HC, Tsao LY, Hsu WY, Chen HN, Yu WK, Chi CY. Relation of cord serum levels of growth hormone, insuline-like growth factors, insuline-like growth factors binding proteins, leptin, and interleukin-6 with birth weight, birth length, and head circumference in term and preterm neonates. Nutrition 2002; 18: 604-608.
36. Nakago S, Ueda Y, Takeuchi K, Maruo T. Implication of maternal nitrogen balance in the regulation of circulating levels of insulin-like growth factor-I in human pregnancy. EndocrJ2002; 49: 299-305.
37. Chen J, Smith LE. Retinopathy of prematurity. Angiogenesis. 2007; 10:133-140.
38. 38. Hellstrom A, Perruzzi C, Ju M, Engström E, Hard A. Liu JL, et al. Low IGF-I suppresses VEGF-survival signaling in retinal endothelial cells: direct correlation with clinical retinopathy of prematurity. Proc Natl Acad Sci USA 2001; 98: 5804-5808. (Pubitemid 32435723)
39. 39. Engström E, Niklasson A, Wikland KA, Ewald U, Hellström A. The rale of maternal factors, postnatal nutrition, weight gain, and gender in regulation of serum IGF-I among preterm infants. Pediatr Res 2005; 57: 605-610. (Pubitemid 40389352)
40. Yeung MY. Somatotropic axis derangement as an underlying factor in the genesis of retinopathy of prematurity. Acta Paediatr 2006; 95:1334-1340.
41. Price WA, Lee E, Maynor A, Stiles AD, Clemmons DR. Relation between serum insulinlike growth factor-1, insulinlike growth factor binding protein-2, and insulinlike growth factor binding protein-3 and nutritional intake in premature infants with bronchopulmonary dysplasia. J Pediatr Gastroenterol Nutr 2001 ; 32: 542-549. (Pubitemid 32605689)
42. 42. Löfqvist CH, Engström E, Sigurdsson J, Hard AL Niklasson A, Ewald U, et al. Postnatal head growth deficit among premature infants parallels retinopathy of prematurity and insulin-like growth factor-1 deficit. Pediatrics 2006; 117:1930-1938. (Pubitemid 46071236)
43. Villegas-Becerril E, González-Fernández R, Perula-Torres L Gaflardo-Galera JM. IGF-I, VEGF y bFGF, como factores pronósticos de la aparición de la retinopatía de la prematuridad. Arch Soc Esp Oftalmol 2006; 81: 641-646.
44. Smith LE. IGF-I and retinopathy of prematurity in the preterm infant. Biol neonate 2005; 88: 237-244.
45. 45. Hughes S, Gardiner T, Baxter L Chan-Ling T Changes in pericytes and smooth muscle cells in the kitten model of retinopathy of prematurity: implications for plus disease. Invest Ophthalmol Vis Sci 2007; 48:1368-1379. (Pubitemid 351261437)
46. Wallace DK, Kylstra JA, Phillips SJ, Hall. JG. Poor postnatal weight gain: a risk factor for severe retinopathy of prematurity. JAAPOS 2000; 4: 343-347.
47. 47. Löfqvist C, Andersson E, Sigurdsson J, Engström E, Hard A. Niklasson A, et al. Longitudinal postnatal weight and insulin-like growth factor I measurements in the prediction of retinopathy of prematurity. Arch Ophthalmol 2006; 124: 1711-1718. (Pubitemid 44913194)
48. Hellström A, Hard AL, Engström E, Niklasson A, Andersson E, Smith L, et al. Early weight gain predicts retinopathy in preterm infants: new, simple, efficient approach to screening. Pediatrics 2009; 123: e638-e.645.
49. Dhaliwal CA, Fleck BW, Wright E, Graham C, Mcintosh N. Retinopathy of prematurity in small-for-gestational age infants compared to appropriate-for- gestational age infants. Arch Dis Child Fetal Neonatal Ed 2008; O: 143552vl.
50. Loos RJ, Derom C, Derom R, Vlientick R. Determinants of birthweight and intrauterine growth in livehom twins. Paediatr Perinat Epidemiol 2005; Sl: 15-22.
51. Filho JB, Bonomo PP, Maia M, Procianoy RS. Weight gain measured at 6 weeks after birth as a predictor for severe retinopathy of prematurity: study with 317 very low birth weight preterm babies. Graefes Arch Clin Exp Ophthalmol 2008; DOI 10.1007/s00417-008-1012-3.